Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in VERTEX PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 3M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $1.4B as of 2025-Q4. The position was increased (++3.9% shares). VRTX represents 0.3% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$1.4B
Current Shares
3M
Total Value Change
+$149.1M
Total Shares Change
+416,451
Other major holders of VRTX: DnB Asset Management AS
Increased |
| 3M |
+3.9% |
| $1.4B |
| 0.3% |
| $453.74 |
40 |
| 2025-Q3 | Decreased | 2.9M | -5.9% | $1.1B | 0.2% | $395.31 | 0 |
| 2025-Q2 | Increased | 3.1M | +19.9% | $1.4B | 0.3% | $441.30 | 45 |
| 2025-Q1 | Increased | 2.6M | +9.9% | $1.2B | 0.3% | $492.69 | 42 |
| 2024-Q4 | Decreased | 2.3M | -4.6% | $938M | 0.2% | $399.35 | 0 |
| 2024-Q3 | Decreased | 2.4M | -5.5% | $1.1B | 0.3% | $462.88 | 0 |
| 2024-Q2 | Increased | 2.6M | +5.7% | $1.2B | 0.3% | $468.72 | 40 |